Advertisement
Screener

Taysha Gene Therapies, Inc. (TSHA) Common Stock, Value, Issued

2.8 / 5 stars · 68/120 Roast Me

Taysha Gene Therapies, Inc. Common Stock, Value, Issued

Taysha Gene Therapies, Inc. (TSHA) had Common Stock, Value, Issued of $3.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:CommonStockValue · last filed 2026-08-11

  • 2026-06-30: Common Stock, Value, Issued $3.00K.
  • 2026-03-31: Common Stock, Value, Issued $3.00K.
  • 2025-12-31: Common Stock, Value, Issued $3.00K.
  • 2025-09-30: Common Stock, Value, Issued $3.00K.
Period endCommon Stock, Value, Issued
2026-06-30$3.00K
10-Q · filed 2026-08-11
2026-03-31$3.00K
10-Q · filed 2026-05-06
2025-12-31$3.00K
10-Q · filed 2026-08-11
2025-09-30$3.00K
10-Q · filed 2025-11-04
2025-06-30$3.00K
10-Q · filed 2025-08-12
2025-03-31$2.00K
10-Q · filed 2025-05-15
2024-12-31$2.00K
10-K · filed 2026-03-19
2024-09-30$2.00K
10-Q · filed 2024-11-13
2024-06-30$2.00K
10-Q · filed 2024-08-12
2024-03-31$2.00K
10-Q · filed 2024-05-14
2023-12-31$2.00K
10-K · filed 2025-02-26
2023-09-30$2.00K
10-Q · filed 2023-11-14
2023-06-30$1.00K
10-Q · filed 2023-08-14
2023-03-31$1.00K
10-Q · filed 2023-05-11
2022-12-31$1.00K
10-K · filed 2024-03-19
2022-09-30$1.00K
10-Q · filed 2022-11-08
2022-06-30$1.00K
10-Q · filed 2022-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunocore Holdings plc (IMCR)$1.613B-90.43
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Vericel Corp (VCEL)United States$2.011B93.97
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10